INVO Bioscience (INVO) Short Interest Ratio & Short Volume

Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 2,000 shares of INVO short. 0.05% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of INVO Bioscience's floating shares are currently sold short.

INVO Bioscience saw a drop in short interest in the month of September. As of September 30th, there was short interest totaling 2,000 shares, a drop of 96.6% from the previous total of 58,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

INVO Bioscience currently has issued a total of 3,809,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 3,880,000 shares.

0.05% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to INVO Bioscience: Lyra Therapeutics, Inc. (3.12%), PAVmed Inc. (3.25%), SeaStar Medical Holding Co. (7.22%), T2 Biosystems, Inc. (14.44%), NeuroMetrix, Inc. (1.08%), Intelligent Bio Solutions Inc. (9.80%), Plus Therapeutics, Inc. (0.91%), Biotricity, Inc. (17.03%), Sharps Technology, Inc. (3.49%), Aethlon Medical, Inc. (2.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks.

Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is September, 30 2024.